Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That is one of the problems investors have with NEPH. They do not PR fluff, and investors love 18 PR's a week.
NEPH is definately an extremely solid investment for the buck. A ton going on for this small company. And they are not even a development stage company anymore - they are selling past FDA approved developments right now and increasing reveneues quarter after quarter after quarter.....etc
Develpment contract with the US Department of Navy for 2 million, development contract with STERIS who are valued at 2 billion dollars, FDA pending approval 1.3 years late (come on FDA!) for a 'first' technology, multiple FDA approved products currently being marketed - how can you go wrong with this?
Does not sound like it, but it does sound like they will be developing other technology/devices similar to the one that is currently under FDA review.
Under the terms of the agreement, Nephros and STERIS will jointly develop filtration-based products for medical device applications. Nephros received an initial payment upon entering into the agreement and is eligible to receive additional payments upon successful completion of product development milestones.
"Nephros is investigating a range of commercial, industrial and retail opportunities for its DSU technology," said Ernest Elgin, President and CEO of Nephros. "We are pleased to be working with STERIS to leverage our expertise in additional applications. STERIS is a leader in the field of medical device sterilization, and we look forward to developing new products together to enhance patient safety."
So basically, they will develop NEW technology (the one under FDA review is a technology already developed, and is soley NEPHS property and no one elses). STERIS will be paying NEPH money to develop products. Even if products are not developed, NEPH is getting paid a set amount. If and when products are developed, i would expect they will belong to both companies, and STERIS will market the products (sell them) and NEPH will receive royalties.
This is very similar, although not exactly the same, as NEPHs deal with the United States Navy to develop mobile water filtration devices. The US Navy is paying NEPH to develop it. Once developed, they Navy will basically buy the units off NEPH.
Thanks for posting Otterman!
This is HUGE news. STERIS is a big time company, and the PR was also released under their ticker (STE).
2 billion market cap, over a quarter billion cash on hand, 327.8 million in sales LAST QUARTER, with 41 million Net Income last quarter (could buy NEPH out with 1 quarters of income)
I really wish NEPH would keep us updated on everything they have going on a little more often. So many things to keep investors excited about, but we are left in the dark and always have to wait for the quarterly's.
Yeah, im about even. My break-even is somewhere between .95 to 1.05 but i lost track of the actual amount it has been so long and i traded half of my position so much.
The thing i like about it is not only will it be more cost efficient, but mid dilution will save more lives.
The problem here Smokey is that the filter and module are for a procedure that has not been approved here in the United States - NEPH is a first device for this. Pre and Post dilution are mainstream, but mid-dilution will be a first.
If Mid-Dilution was already practiced here in the United States like it is in Europe, this would have been approved long ago.
Really, its not taking the FDA so long because of the device, but because of the procedure the device is used for, which right now, is not practiced here.
However, from lightly reading about mid-dilution, it seems superior to pre and post dilution. So it is just a matter of time IMO.
Shameless.
Non GAAP, which i cannot stand. Too fishy. Wish they reported in GAAP also.
Regardless, looks good except for the delays in Q4, which investors should watch closely since more delays or even cancels could come in the future if the global economy keeps lingering.
Just something to watch closely.
Great Q and year though.
Thanks Maddog. Was just lazy and did not look at when last years 4th was released.
What happened to sexqube TV? When did this become gleeworks?
Did you guys notice his other one? Suprised they got it that high.
How is everyone hanging in there?
Remember, this is Q4 for NEPH, which means year end, which means, up to an extra 45 days to file for EOY.
NEPH Q4 coming soon
year end should be out within a month, so we should have many, many answers then (hopefull)
oh brother. What will he come up with next?
I continue to watch LDK closely. Mad i did not invest in Trina when it was like 5 bucks. Grrrr.
This scam did not have 200% profit. Show me an audited sarbanes-oxley financial report of it, and ill show you a picture of me with Darth Vader on the Death Star.
The problem with optimism, and believe it or not, there is some if everything that Robert has stated is indeed fact and not fluff, is this.....
There have been Tens and Tens and Tens of millions of shares dumped to us retail traders from .05 all the way down to .00000005 or whatever we are at at this moment.
That means, once the 'seller' (which i call BS to, but lets just say he is being honest with this story) that once they start selling $10,000 worth of veggie dip, and some people buy shares, this has SUCH a HUGE ceiling of resistance levels to chew through to not only get back to a nickel, but to even 3 cents or 2 cents even, that it would take a PR like this to break through it all....
'Walmart purchases 1 billion worth of Natures Peak Veggie Spread, ticker symbol EVRN.pk'
Of course i'm being a little dramatic here, but not far from the truth. At this point, im 98% sure Robert has been dishonest, this is a scam, and i would LOVE to meet this guy for all the wrong (or should i say right) reasons.
Anyway, Merry Christmas everyone. Hope everyone enjoys this holiday.
We need to hire a 'Dexter' to start making these pinksheet scammers more accountable, then they will start to become more accountable and honest going forward.
By my estimations (last quarteryly plus recent financing activity) NEPH should have approximately 3.5 million in cash/cash equivelant on hand.
NEPH Burnt 1.7 million in cash in the trailing 9 quarters, but are burning less and less cash each quarter going forward due to higher sales of products combined with no trials for potential products (R&D) outside the Navy Contract.
The way i figure it, This recent financing gives NEPH a solid 2 years before 1 of 2 things happen:
1) they need to finance again to raise money because their current business is not self-sustaining
2) their current business becomes self-sustaining, and they no longer need to raise cash through financing because they are in the black
Now, i have posted numerous times how close to black (making money, not losing it) they are getting quarter after quarter after quarter, but i will post again......
Quarter - Revenue - Income --- EPS
Q3 _______ 711k ___ (395k) __ (.01)
Q2 _______ 527k ___ (413k) __ (.01)
Q1 _______ 631k ___ (740k) __ (.02)
Q4 _______ 440k ___ (910k) __ (.03)
Q3 _______ 390k __ (1,350k) _ (.04)
Q2 _______ 253k __ (2,444k) _ (.06)
Now, even without their current OLPUR module approved, they are getting VERY close and growing revenues very handsomely (thus, reducing loss heavily also).
Once the Navy contract is successful OR/AND the OLPUR is approved, not only will the business be self sustaining as they are a lock to bank profit, but we will additionally see the stock price soar.
As a matter of a fact, there is a great discussion that NEPH very likely will be bought out - and if that happens i would guess it will be for approximately $8 a share (300 to 350 million dollars)
They are simply in the early stages of a development company selling a few water filters to hospitals right now and selling 3 million a year - imagine not only more growth here, but the portable armed forces water filter combined with the big hitter, OLPUR module.
I posted long ago that i covered. Made good.
One thing i will say is that General Motors will come out of this last cycle much, much stronger than Ford. Ford is much, much stronger than Chrysler though.
I am expecing Chrysler to fail in the future. I am expecting Chrysler to sell off their jeep division. They need cash extremely bad.
If GM issued free trading stock in the 'new GM', i would be all in that. Ford did it the right way, especially for shareholders, but GM will come out much stronger by next to completely wiping off or greatly reducing most legacy costs.
FDA approval, or FDA decision?
And i have not done this yet, but others that have said adding the paypal feature to your site takes less than 20 minutes for an experienced web programmer.
If you know absolutely nothing about web programming, it will take about 4 hours, or less than a day to do yourself. I guess it is that easy.
And who is doing the financing?
Matter of fact, i find it nearly impossible to believe now that they ARENT selling, since there have been it seems a quadrillion shares dumped and price battered down to nothingless since they fed us the line that this selling was the ex-CEO's fault.
We DONT know if they are selling. The TA is gagged. The company can tell us whatever they feel.
Well, i did get out the majority when i found out the TA was gagged. I still have 78k shares though. I had 210k origninally at a nickel. What a dufus i am, investing 10,000 dollars into a pinksheet company that made 6 veggie spreads, and were not even in full production yet!
I had it coming.
I will lose $6,200 of my original 10k investment if this goes to zero.
At least i can pat myself on the back a little for selling almost 2/3 of my shares after finding the TA was gagged a while back.
Still, fool me once, shame on you, fool me twice, shame on me.
And its shame on me time.
Yep. Worst investment i have made to date, beating out a scam i invested in a few years back.
Grrrrr. I took this one on the recommendation of another investor too. Double Grrrrr.
Inkster, home of the nations #1 QB recruit. I am from Bay City, work in Saginaw, live in Freeland.
Excellent contribution to the board. Well thought out post. Great DD.
Very, very true and excellent advice.
Not CCC, but let me ask you:
Do you truly beleive that Ampligen will be approved?
If not, sell now.
If so, you have 2 options:
1) Sell now, hope the price goes lower than the price you sell it for in the next 2 years, buy back more shares with same investment you sold.
2) Sit, hold and relax and dont look at it, since you feel it will eventually be approved.
IMO, it will be a better buy opportunity later than sooner. I think the best decision would be to sell and buy back when the smoke clears and this stabilizes. And only buy back if you truly believe HEB/Management can get all their ducks in a row.
Next decision of Ampligen is now at minimum 1 year out, probably 2 years out. I dont think any investor would want to be tied up that long and miss 100 boats elsewhere when you can come back into this much, much later in the game when you see things progressing.
And with Carter, even if you read that things are progressing, are they really?
As i have said in the past, i havent owned this in quite some time. Sold tons 3.1 to 3.15 and the rest over 2.5 and have not held since. They just did not give me reason to buy back, even when it hit 2 and everyone said it was cheap, and when it hit 1.5 and everyone said back up the truck, then at 1.00 when everone said mortgage the house, and now at .75 i have read posts that it is cheap again.
No thanks.
Your correct shotcallers. They will get approval IMO on the Olpur module. The question is, when? Should have been 6 months ago.
But, worst case scenario that for some reason the FDA wants even more info and this gets drawn out, NEPH with its current products is soooooo close to breakeven.
Sorry for everyones loss on this one. What once was sooooo promising has turned for the worse.
Keep your head up and make it back somewhere else folks!
Mine had been approximately $10 and still is. It is just that my chance of approval is lower than it used to be, and im sure most feel the same, hence the lower share price right now (more risk)
HEB and NEPH are taking so long, i dont know if i can take investing into another FDA play again!
UGGGH!
Sure does make you think twice, 3 times etc... while watching the portfolio dip down.
Still think > 90% chance of approvol, but man, sure the heck don't know when the decision will come.
I honestly just wish the decision would get here, good or bad, so i can move on. This has been an extremely frustrating wait.
NEPH
Dual Stage Ultrafilter (DSU)
On 10-7-2008 Nephros filed a 510(k) application for approval to market Dual Stage Ultrafilter to dialysis clinics for in-line purification of dialysate water. FDA requested additional information from Nephros in regards to DSU 510(k) application. On 2-24-2009, Nephros provided a formal response to the FDA. On 7-1-2009, Nephros received FDA approval of the DSU to be used to filter biological contaminants from water and bicarbonate concentrate used in hemodialysis procedures. * FDA approval came 39 days late *
* On this approval, NEPH shot up from 1.02 previous close to an intraday high of 1.59, a 56% gain *
OLpur H2H Module and OLpur MD 220 Filter
First quarter of 2007, Nephros received approval from the FDA for their Investigational Device Exemption ("IDE") application for the clinical evaluation of our OLpur H2H module and OLpur MD 220 filter. Second quarter of 2008 Nephros completed the patient treatment phase of their clinical trial. On 11-4-2008, Nephros submitted the data to the FDA with their 510(k) application on these products. FDA requested additional information from Nephros in regards to OLpur H2H Module and OLpur MD 220 Filter. On 3-13-2009 Nephros replied the the FDA request with additional information. The FDA has not provided Nephros with any additional requests for information or rendered a decision on Nephros application. Nephros have made inquiries to the FDA about the status of their application and have been informed that their application is still under their review process. * Approval is currently 155 days late from the 90 days given from NEPH'S reply for more information *
FINANCIALS (last 6 quarters)
Quarter - Revenue - Income --- EPS
Q3 _______ 711k ___ (395k) __ (.01)
Q2 _______ 527k ___ (413k) __ (.01)
Q1 _______ 631k ___ (740k) __ (.02)
Q4 _______ 440k ___ (910k) __ (.03)
Q3 _______ 390k __ (1,350k) _ (.04)
Q2 _______ 253k __ (2,444k) _ (.06)